Company intelligence / Profile preview

1Yaowang

Shanghai, Shanghai Municipality, China

Ownership: Private
Development stage: Other

Overview

1Yaowang operates as a major online pharmacy and healthcare portal in China, providing B2B and B2C drug sales, telemedicine, and health consultation to millions of users. It does not conduct its own clinical trials or have its own drug development pipeline, but acts as a marketplace/aggregator for medicines and health services

Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

J.P. MorganCitibankCICCmajor pharmaceutical producersdigital health companies

Beyond the preview

Go deeper on 1Yaowang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1Yaowang.

Explore the full profile